Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin

European Journal of Pharmacology

Volumn 476, Issue 1-2, 2003, Pages 87-95

  Bedendi, Ivano ^a   Alloatti, Giuseppe ^a   Marcantoni, Andrea ^a   Malan, Daniela ^a   Catapano, Filomena ^a   Ghé, Corrado ^a   Deghenghi, Romano ^b   Ghigo, Ezio ^b   Muccioli, Giampiero ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Ca2+ current; Cardiac contractility; Endogenous; GH secretagogues receptor; Ghrelin; Ghrelin derivative; Growth hormone secretagogue

Indexed keywords

CALCIUM CHANNEL L TYPE; DESOCTANOYLGHRELIN; GHRELIN; GHRELIN[14 DEGLUTAMINE]; GROWTH HORMONE SECRETAGOGUE; HEXARELIN; PROSTAGLANDIN SYNTHASE; SYNTHETIC PEPTIDE; TYRAMINE; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ISOLATION; CELL MEMBRANE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ENDOCARDIUM; ENDOTHELIUM; ENZYME INHIBITION; FEMALE; GUINEA PIG; HEART CONTRACTION; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TENSION;

EID: 0142200403     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02083-1     Document Type: Article

References (35)

1. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159:2002;1029-1037.
2. Bedendi I., Gallo M.P., Malan D., Levi R.C., Alloatti G. Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle. Life Sci. 69:2001;2189-2201.
3. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., Warren V.A., Howard A.D., Van Der Ploeg L.H., Heck J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43:2001;4370-4376.
4. Bisi G., Podio V., Valetto M.R., Broglio F., Bertuccio G., Amaretti G., Pelosi E., Del Rio G., Muccioli G., Ong H., Boghen M.F., Deghenghi R., Ghigo E. Cardiac effects of hexarelin in hypopituitary adults. Eur. J. Pharmacol. 381:1999;31-38.
5. Bodart V., Bouchard J.F., McNicoll N., Escher E., Carrière P., Ghigo E., Sejlitz T., Sirois G., Lamontagne D., Ong H. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circ. Res. 85:1999;796-808.
6. Brixius K., Pietsch M., Schwinger R.H. The intracellular Ca(2+)-homeostasis influences the frequency-dependent force-generation in man. Basic Res. Cardiol. 94:1999;152-158.
7. Broglio F., Fubini A., Morello M., Arvat E., Amaretti G., Gianotti L., Boghen M.F., Deghenghi R., Mangiardi L., Ghigo E. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin. Endocrinol. 50:1999;417-430.
8. Cassoni P., Papotti M., Ghè C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E., Muccioli G. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 86:2001;1738-1745.
9. Colao A.M., Marzullo P., Di Somma C., Lombardi G. Growth hormone and the heart. Clin. Endocrinol. 54:2001;137-154.
10. Filigheddu N., Fubini A., Baldanzi G., Cutrupi S., Ghè C., Catapano F., Broglio F., Bosia A., Papotti M., Muccioli G., Ghigo E., Deghenghi R., Graziani A. Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Endocrine. 14:2001;113-119.
11. Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone-releasing peptides. Eur. J. Endocrinol. 136:1997;445-460.
12. 14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J. Biol. Chem. 275:2000;21995-22000.
13. Hosoda H., Kojima M., Matsuo H., Kangawa K. Ghrelin and des-octanoyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 279:2000;909-913.
14. Imazio M., Bobbio M., Broglio F., Benso A., Podio V., Valetto M.R., Bisi G., Ghigo E., Trevi G.P. GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. Eur. J. Heart Fail. 4:2002;185-191.
15. 9]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br. J. Pharmacol. 134:2001;143-149.
16. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660.
17. Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12:2001;118-122.
18. Locatelli V., Rossoni G., Schweiger F., Torsello A., De Gennaro Colonna V., Bernareggi M., Deghenghi R., Müller E.E., Berti F. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology. 140:1999;4024-4031.
19. Matsumura K., Tsuchihashi T., Fujii K., Abe I., Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension. 40:2002;694-699.
20. Mebazaa A., Martin L.D., Robotham J.L., Maeda K., Gabrielson E.W., Wetzel R.C. Right and left ventricular cultured endocardial endothelium produces prostacyclin and PGE2. J. Mol. Cell. Cardiol. 25:1993;245-248.
21. Muccioli G., Ghé C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., Nilsson M.H., Deghenghi R., Ong H., Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 157:1998;99-106.
22. Muccioli G., Broglio F., Valetto M.R., Ghé C., Catapano F., Graziani A., Papotti M., Bisi G., Deghenghi R., Ghigo E. Growth hormone-releasing peptides and the cardiovascular system. Ann. Endocrinol. (Paris). 61:2000;27-31.
23. 125I-labelled ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 24:2001;RC7-RC9.
24. Muccioli G., Tschöp M., Papotti M., Deghenghi R., Heiman M., Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implication in metabolism and obesity. Eur. J. Pharmacol. 440:2002;235-254.
25. Müller E.E., Locatelli V., Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol. Rev. 79:1999;511-607.
26. Müller E.E., Rigamonti A.E., De Gennaro Colonna V., Locatelli V., Berti F., Cella S.G. GH-related and extra-endocrine actions of GH secretagogues in aging. Neurobiol. Aging. 23:2002;907-919.
27. Nagaya N., Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr. Opin. Pharmacol. 3:2003;146-151.
28. Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H., Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol. 39:2002;779-783.
29. Osterziel K.J., Ranke M.B., Strohm O., Dietz R. The somatotrophic system in patients with dilated cardiomyopathy: relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function. Clin. Endocrinol. 53:2000;61-68.
30. Papotti M., Ghé C., Cassoni P., Catapano F., Deghenghi R., Ghigo E., Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 85:2000;3803-3807.
31. Pettersson I., Muccioli G., Granata R., Deghenghi R., Ghigo E., Ohlsson C., Isgaard J. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J. Endocrinol. 175:2002;201-209.
32. Smith R.G., Van der Ploeg L.H.T., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J. Jr., Fisher M.H., Nargund R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 18:1997;621-645.
33. Torsello A., Ghé C., Bresciani E., Catapano F., Ghigo E., Deghenghi R., Locatelli V., Muccioli G. Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology. 143:2002;1968-1971.
34. Torsello A., Bresciani E., Rossoni G., Avallone R., Tulipano G., Cocchi D., Bulgarelli I., Deghenghi R., Berti F., Locatelli V. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology. 144:2003;1787-1792.
35. Wiley K.E., Davenport A.P. Comparison of vasodilatators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br. J. Pharmacol. 136:2002;1146-1152.